In an animal model of chlorhexidine gluconate-induced peritoneal fibrosis, inhibition of TGF-β receptor inhibitor reduced fibrosis, VEGF-A expression, and CD-31-positive vessels, indicating that inhibition of fibrosis reduces neoangiogenesis. This evidence concerns the gene PECAM1 and Peritoneal Fibrosis.